Kristin Houser is a staff writer at Freethink, where she covers science and tech. Her written work has appeared in Business Insider, NBC News, and the World Economic Forum’s Agenda, among other publications, and Stephen Colbert once talked about a piece on The Late Show, to her delight.
Prior to joining Freethink, Kristin was a staff writer for Futurism and wrote several animated and live action web series.
Recent Work by Author
A prescription-only app that treats nightmare disorder is the latest in a growing subset of health technologies called prescription digital therapeutics.
Using CRISPR, scientists have identified a gene that could determine whether coral reefs are highly susceptible to bleaching or not.
Several developers have reported incredible coronavirus vaccine progress, so when will we have a COVID-19 vaccine ready for distribution?
The University of Oxford's COVID-19 vaccine was up to 90% effective in a phase 3 trial and could be easier to distribute than other coronavirus vaccines.
Coronavirus immunity might last for years, according to a new study that measured the levels of virus-fighting immune cells in COVID-19 survivors.
By adding two “boosters” to an in-development skin cancer vaccine, scientists may have improved its ability to prevent melanoma recurrence.
A new laser beam may allow scientists to control lightning, allowing them to divert a bolt to strike where it’s less likely to cause a wildfire.
Using a bioreactor packed with bacteria could make space mining more efficient by speeding up the extraction of elements from rock.
A new kind of hydrogel dressing improves wound healing and minimizes scarring by kicking the adaptive immune system into gear.